Latest News

  • 9th March 2026

    Arecor to present at Oppenheimer Annual Healthcare MedTech & Services Conference (16 March 2026)

    ↓ DOWNLOAD PDF
  • 23rd February 2026

    Arecor talks to Biotech TV

    CLICK HERE
  • 7th January 2026

    Arecor and Sequel Med Tech Fireside Panel Discussion

    CLICK HERE

News

Reset
  • 04/12/2023

    ARECOR SIGNS AGREEMENT WITH GLOBAL MEDICAL PRODUCTS COMPANY

    ↓ DOWNLOAD PDF
  • 29/11/2023

    ARECOR CONTINUES COLLABORATION WITH LILLY

    ↓ DOWNLOAD PDF
  • 17/11/2023

    FIRST PRODUCT INCORPORATING ARECOR’S ARESTAT TECHNOLOGY, AT220, LAUNCHED IN EUROPE

    ↓ DOWNLOAD PDF
  • 02/11/2023

    INHIBRX MILESTONE TRIGGERS PAYMENT TO ARECOR UNDER LICENSE AGREEMENT

    ↓ DOWNLOAD PDF
  • 07/09/2023

    ARECOR ANNOUNCES POSITIVE PRE-IND MEETING WITH FDA FOR NOVEL READY-TO-USE MEDICINE AT307 LICENSED TO HIKMA

    ↓ DOWNLOAD PDF
  • 04/09/2023

    TETRIS PHARMA ANNOUNCES COMMERCIALISATION AGREEMENT WITH GOODLIFE

    ↓ DOWNLOAD PDF
  • 17/08/2023

    ARECOR TO COLLABORATE WITH TOP 10 GLOBAL PHARMACEUTICAL COMPANY

    ↓ DOWNLOAD PDF
  • 05/07/2023

    ARECOR ANNOUNCES ADDITIONAL AGREEMENT WITH LEADING BIOPHARMACEUTICAL COMPANY

    ↓ DOWNLOAD PDF
  • 26/06/2023

    ARECOR PRESENTS POSITIVE DATA FROM US PHASE I CLINICAL TRIAL OF ULTRA-RAPID ACTING INSULIN CANDIDATE AT247 DELIVERED VIA INSULIN PUMP AT ADA ANNUAL MEETING

    ↓ DOWNLOAD PDF
  • 27/06/2023

    ARECOR GRANTED KEY PATENTS IN EUROPE AND CHINA TO PROTECT PROPRIETARY INSULIN PRODUCTS

    ↓ DOWNLOAD PDF
  • 15/05/2023

    TETRIS PHARMA LAUNCHES OGLUO® IN DENMARK AND NORWAY

    ↓ DOWNLOAD PDF
  • 26/04/2023

    US PATENT GRANTED PROTECTING PROPRIETARY FORMULATIONS OF MONOCLONAL ANTIBODIES

    ↓ DOWNLOAD PDF
  • 05/04/2023

    ARECOR APPOINTS DR. MANJIT RAHELU AS CHIEF BUSINESS OFFICER

    ↓ DOWNLOAD PDF
  • 12/03/2023

    ARECOR FEATURED IN THE MAIL ON SUNDAY’S MIDAS COLUMN

    ↓ CLICK HERE
  • 22/03/2023

    FIRST PATIENT DOSED IN SECOND PHASE I CLINICAL TRIAL OF AT278

    ↓ DOWNLOAD PDF
  • 16/02/2023

    ARECOR GRANTED PATENTS IN INDIA AND THE UNITED STATES PROTECTING PROPRIETARY FORMULATIONS

    ↓ DOWNLOAD PDF
  • 14/02/2023

    ARECOR STRENGTHENS COLLABORATION WITH TOP 5 GLOBAL PHARMACEUTICAL PARTNER THROUGH ADDITIONAL FORMULATION AGREEMENT

    ↓ DOWNLOAD PDF
  • 30/01/2023

    ARECOR ANNOUNCES PUBLICATION OF PHASE I DATA FOR AT278 IN DIABETES CARE

    ↓ DOWNLOAD PDF
  • 12/01/2023

    ARECOR ANNOUNCES TRANSFER OF AT307 TO HIKMA

    ↓ DOWNLOAD PDF
  • 04/01/2023

    TETRIS PHARMA LAUNCHES OGLUO® IN AUSTRIA

    ↓ DOWNLOAD PDF